Canntab Therapeutics Announces Engagement of Relations Publiques Paradox Inc. for Investor Relations Services
March 28, 2019 08:30 ET
|
Canntab Therapeutics Limited
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, March 28, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL) (the “Company” or “Canntab”) is...